Iambic Announces Pricing of Initial Public Offering
Iambic official newsroom · 行业原文收录 · 来源发布:Wed Oct 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录:Thu Oct 15 2026 00:07:40 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
SAN DIEGO, Calif., October 14, 2026 – Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, today announced the pricing of its initial public offering of 9,375,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Iamb
以上为带出处的原文节选,完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。